TPCW
MRK icon

TD Private Client Wealth’s Merck MRK Stock Holding History

TD Private Client Wealth’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.19M Buy
63,772
+4,356
+7% +$510K 0.15% 93
2026
Q1 		$7.15M Buy
59,416
+20,402
+52% +$2.36M 0.15% 94
2025
Q4 		$4.11M Buy
39,014
+14,533
+59% +$1.36M 0.09% 151
2025
Q3 		$2.05M Sell
24,481
-38,683
-61% -$3.19M 0.05% 236
2025
Q2 		$5M Sell
63,164
-15,010
-19% -$1.19M 0.12% 123
2025
Q1 		$7.02M Buy
78,174
+9,258
+13% +$864K 0.19% 86
2024
Q4 		$6.86M Sell
68,916
-14,123
-17% -$1.46M 0.19% 80
2024
Q3 		$9.43M Sell
83,039
-3,688
-4% -$438K 0.27% 63
2024
Q2 		$10.7M Sell
86,727
-2,363
-3% -$304K 0.34% 53
2024
Q1 		$11.8M Buy
89,090
+3,598
+4% +$443K 0.39% 50
2023
Q4 		$9.32M Buy
85,492
+504
+0.6% +$52.3K 0.34% 54
2023
Q3 		$8.75M Sell
84,988
-9,458
-10% -$1.02M 0.38% 47
2023
Q2 		$10.9M Sell
94,446
-578
-0.6% -$65.6K 0.47% 37
2023
Q1 		$10.1M Sell
95,024
-15,013
-14% -$1.62M 0.45% 41
2022
Q4 		$12.2M Sell
110,037
-25,335
-19% -$2.59M 0.58% 36
2022
Q3 		$11.7M Sell
135,372
-10,951
-7% -$978K 0.6% 30
2022
Q2 		$13.3M Sell
146,323
-35,710
-20% -$3.17M 0.65% 29
2022
Q1 		$14.9M Buy
182,033
+10,709
+6% +$844K 0.64% 25
2021
Q4 		$13.1M Sell
171,324
-24,885
-13% -$1.98M 0.55% 32
2021
Q3 		$14.7M Sell
196,209
-304
-0.2% -$23.1K 0.63% 29
2021
Q2 		$15.3M Buy
196,513
+33,498
+21% +$2.49M 0.65% 26
2021
Q1 		$12M Buy
163,015
+17,545
+12% +$1.29M 0.56% 33
2020
Q4 		$11.4M Sell
145,470
-6,540
-4% -$500K 0.58% 32
2020
Q3 		$12M Sell
152,010
-5,870
-4% -$460K 0.67% 26
2020
Q2 		$11.6M Buy
157,880
+44,234
+39% +$3.33M 0.68% 30
2020
Q1 		$8.34M Buy
113,646
+46,127
+68% +$3.63M 0.6% 34
2019
Q4 		$5.86M Buy
+67,519
New +$5.55M 0.35% 65

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TD Private Client Wealth's MRK Position: Q2 2026 in Review

TD Private Client Wealth increased its Merck (MRK) stake by 7.3% in Q2 2026, buying an estimated $510K and bringing the position to 63,772 shares worth $8.19M. The position accounts for 0.15% of the portfolio, ranked #93.

TD Private Client Wealth first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $15.3M in Q2 2021. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TD Private Client Wealth held 63,772 shares of Merck worth $8.19M as of Q2 2026.
  • TD Private Client Wealth bought 4,356 Merck shares in Q2 2026, an estimated $510K.
  • Merck made up 0.15% of TD Private Client Wealth's portfolio in Q2 2026, its #93 holding.
  • TD Private Client Wealth first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Merck position peaked at $15.3M in Q2 2021.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.